Ann Arbor Stage III Non-Hodgkin Lymphoma Recruiting Phase 2 Trials for Hydrogen (DB15127)

IndicationStatusPhase
DBCOND0093345 (Ann Arbor Stage III Non-Hodgkin Lymphoma)Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT03155620Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors, Non-Hodgkin Lymphomas, or Histiocytic Disorders (The Pediatric MATCH Screening Trial)Screening